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Abstract The Neurotransmitter:Sodium Symporters (NSSs) represent an important class of
proteins mediating sodium-dependent uptake of neurotransmitters from the extracellular space.
The substrate binding stoichiometry of the bacterial NSS protein, LeuT, and thus the principal
transport mechanism, has been heavily debated. Here we used solid state NMR to specifically
characterize the bound leucine ligand and probe the number of binding sites in LeuT. We were able
to produce high-quality NMR spectra of substrate bound to microcrystalline LeuT samples and
identify one set of sodium-dependent substrate-specific chemical shifts. Furthermore, our data
show that the binding site mutants F253A and L400S, which probe the major S1 binding site and
the proposed S2 binding site, respectively, retain sodium-dependent substrate binding in the S1
site similar to the wild-type protein. We conclude that under our experimental conditions there is
only one detectable leucine molecule bound to LeuT.
DOI: 10.7554/eLife.19314.001
Introduction
The Neurotransmitter:Sodium Symporters (NSSs) are responsible for clearing neurotransmitters,
such as dopamine, serotonin, norepinephrine, glycine and GABA from the synaptic cleft. The trans-
porters are thereby crucial for the regulation of synaptic transmission in the CNS and alterations in
their function have been linked to several psychiatric and neurological disorders such as depression,
bipolar disorders, attention deficit hyperactive disorder (ADHD), epilepsy, and Parkinson’s disease
(Broer, 2013; Kristensen et al., 2011). The understanding of the molecular mechanisms and struc-
tural (re)arrangements underlying NSS function has advanced significantly in recent years. The most
detailed insight into structure-function relationships of NSSs comes from studies of the amino acid
transporter, LeuT, from Aquifex aeolicus (Kantcheva et al., 2013; Kazmier et al., 2014;
Malinauskaite et al., 2014, 2016; Piscitelli et al., 2010; Quick et al., 2012; Shi et al., 2008;
Singh et al., 2007; Wang et al., 2012a, 2012b; Yamashita et al., 2005). Recent structures of the
Erlendsson et al. eLife 2017;6:e19314. DOI: 10.7554/eLife.19314 1 of 9
SHORT REPORT
drosophila dopamine transporter (dDAT) (Penmatsa et al., 2013) and the human serotonin trans-
porter (Coleman et al., 2016), which are eukaryotic members of the NSS family, confirm that LeuT is
a reliable model protein and proves its value in understanding the molecular function of this class of
transporters.
Functional studies of LeuT have suggested the existence of a secondary substrate binding site
(S2) located in the extracellular vestibule of LeuT approximately 10 A˚ from the primary substrate
binding site (S1) (Khelashvili et al., 2013; Quick et al., 2009; Shi et al., 2008). The S2 site is sug-
gested to be an allosteric trigger, essential for coupling the energy from the electrochemical gradi-
ent to the transport of the solute. The binding of leucine to the S2 site has been measured to have
the same affinity (in nM range) as binding to the S1 but does not, as the S1 bound substrate, directly
coordinate sodium (Quick et al., 2012). However, attempts to crystallize LeuT with substrate bound
to the S2 site have so far been unsuccessful, and therefore the existence of the S2 site is supported
primarily by radioligand binding assays and guided MD simulations (Quick et al., 2012; Zhao et al.,
2011). Due to the lack of structural evidence, the existence of a high-affinity S2 site has been ques-
tioned (Piscitelli et al., 2010), supporting the need for employing new techniques for investigating
ligand binding in NSS proteins.
Here we investigate the leucine binding properties of LeuT by magic angle spinning (MAS) NMR,
aiming at a characterization of the proposed S2 binding site. Our approach offers several advan-
tages: (i) We use microcrystalline samples of LeuT prepared under experimental conditions allowing
for conformations capable of ligand binding to both S1 and S2 (Quick et al., 2012). (ii) NMR offers
information on the full structural ensemble which is unlikely not to include conformers (even lowly
populated) prone to bind leucine in S2. (iii) Leucine binding to S1 and S2 may be distinguished by
eLife digest All living cells need amino acids – the building blocks of proteins – in order to
survive, yet few cells can make all the amino acids that they need. Instead, transporter proteins in
cell membranes must take these molecules from the outside of the cell and release them to the
inside. Some cells, including those in the brain, also release amino acids and molecules derived from
them into the spaces outside of the cell to send signals to other nearby cells. Again, transporter
proteins must move these signaling molecules back inside cells, to stop the signaling and to allow
the molecules to be recycled. Importantly, problems with these uptake mechanisms have been
linked to disorders such as depression, epilepsy and Parkinson’s disease.
One family of transporters involved in the uptake of amino acids are the “Neurotransmitter:
Sodium Symporters”. Though these proteins are involved in processes that are fundamental to life,
it remains unclear exactly how they work. Specifically, it has been heavily debated whether this
family of transporters require one or two amino acid molecules to bind at the same time in order to
help transport them across the membrane.
Now Erlendsson, Gotfryd et al. have analyzed a bacterial protein in the Neurotransmitter:Sodium
Symporter family. This transporter takes up an amino acid called leucine into cells, and is commonly
used as a model to understand this family of transporter proteins more generally. Using a technique
called solid state nuclear magnetic resonance, Erlendsson, Gotfryd et al. could detect a single
molecule of leucine bound to each transporter, but not a second one. This technique could also
pinpoint that the leucine was located at the transporter’s central binding site. Leucine was never
found at the proposed secondary binding site. Together these findings suggest that only one
molecule of leucine binds to the transporter at any one time, and that it binds to the transporter’s
central binding site.
Erlendsson, Gotfryd et al. have shown now how solid state nuclear magnetic resonance can be
used to explore in detail how Neurotransmitter:Sodium Symporters move molecules across cell
membranes. The next challenge is to use the same experimental setup to characterize other
Neurotransmitter:Sodium Symporters. Doing so could potentially lay the groundwork for designing
more specific and improved drugs to treat disorders like depression and Parkinson’s disease.
DOI: 10.7554/eLife.19314.002
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characteristic chemical shifts that are expected to be different due to different chemical environ-
ments, i.e. interacting residues (Reyes et al., 2011).
Results and discussion
Prior to crystallization and NMR experiments we verified the functionality of the produced LeuT
wild-type (WT) samples. We initially performed [3H]leucine saturation binding experiments and sub-
sequently assessed Na+-dependency of [3H]leucine binding. All experiments were done at a DDM
concentration commonly used in in vitro assays (i.e., 0.05% corresponding to 5.7x CMC). At this
detergent concentration, LeuT was reported to retain binding to both S1 and the putative S2 site
(Quick et al., 2012). In scintillation proximity binding assays LeuT WT bound [3H]leucine with a disso-
ciation constant (Kd) of 12 ± 1 nM in the presence of 200 mM sodium. The EC50 value calculated for
the Na+-dependent binding was 47 ± 4 mM (Figure 1—figure supplement 1A–B). These values are
in agreement with those previously reported for LeuT (Shi et al., 2008; Singh et al., 2008).
As we were primarily interested in a simple readout reporting solely on substrate binding, we
purified and kept LeuT in the presence of 1 mM 15N enriched L-leucine to ensure substrate binding
and detection in both sites (Figure 1A). With a 15N natural abundance around 0.3%, the background
from the protein amides and amines is sufficiently low to distinguish even weakly populated states
originating from the enriched substrate only.
To achieve sufficiently narrow line widths of the NMR signals and to avoid any signal from
unbound leucine, we produced microcrystalline samples of LeuT (Figure 1—figure supplement 2),
and performed cross polarization (CP)-based NMR experiments at temperatures above the freezing
point. In all other preparations tested (frozen, lyophilized and proteoliposomes) the signal from the
unspecific or unbound leucine completely dominated the spectra (Figure 1—figure supplement
3A–B). Using the microcrystalline preparations, we were able to produce the high quality CP-based
15N detected spectra showing one significant (above 2s – Figure 1—figure supplement 4) peak at
38.2 ppm that could be assigned to the amine of protein bound leucine (Figure 1B). In addition to
the sharp signal from leucine, much broader signals between 110 and 130 ppm were also observed,
which originate from the 15N natural abundance of the LeuT amides (Figure 1B). To further assess
whether the intense signal at 38.2 ppm reflects sodium specific leucine binding to LeuT, we per-
formed a parallel experiment substituting Na+ with K+. Sodium is required for leucine binding
(Zhao et al., 2011). By the use of 23Na-NMR we confirmed the presence of only a negligible amount
of residual NaCl (at 7.1 ppm), and that no detectable Na+ was coordinated in the protein
(Figure 1C). In the absence of Na+, the signal at 38.2 ppm in the 15N 1D spectrum disappeared as
expected for a signal originating from 15N-leucine bound to LeuT (Figure 1B). Worth of note, the
amine NH3
+ group of free leucine has a chemical shift of approximately 41 ppm at pH 8 (Figure 1—
figure supplement 5A–B), demonstrating that the bound substrate resides in a not fully solvent
accessible environment. Importantly, we were unable to detect any signal from any additionally
bound leucine. Similarly, the 13C CP/MAS spectra from the same samples clearly displayed only one
single set of sodium dependent leucine signals (Figure 1—figure supplement 6).
To investigate whether the origin of the substrate peak at 38.2 ppm was due to leucine binding
either to the S1 or the S2 site, we recorded solid state NMR spectra of two variants with compro-
mised leucine binding, F253A (S1) and L400S (S2) (Figure 2A,B). For these experiments we lowered
the final concentration of the added enriched substrate to 5 mM to ensure proper detimental effect
by the mutations. This concentration has previously been reported not to provide any detectable
[3H]leucine occupancy in the S2 site of LeuT L400S, but saturated S1 binding (Quick et al., 2012).
For LeuT WT the specific leucine peak was unaffected by lowering the free leucine concentration
(Figure 2—figure supplement 1). The F253A mutant has previously been shown to impair binding
to the S1 site (Billesbølle et al., 2015; Wang et al., 2012b). Thus, F253A serves as a S1 disturbing
mutant at low substrate concentrations. In the F253A 1D 15N spectrum, we observed sodium depen-
dent substrate binding with a chemical shift of 38.4 ppm and a slightly lower signal intensity, when
compared to the WT spectra (Figure 2C). The shift in F253A was consistent for both high (1 mM)
and low (5 mM) leucine concentrations (Figure 2—figure supplement 3). Most importantly, the
chemical shift difference of ~0.2 ppm for the observed bound leucine peak, demonstrates that the
ligand is affected by the local environment of the S1 binding site. The L400S mutation was previously
suggested to abolish S2 leucine binding (Quick et al., 2012). The 15N spectrum obtained for leucine
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bound to L400S (Figure 2C, blue) completely resembled the spectrum obtained with WT protein
(Figure 2C, red). We were not able to detect any change in intensity or chemical shift. This argues
against the possibility that the substrate signal we observe in LeuT WT samples is reporting on a
combination of S1 and S2 binding. Also, we reason that it would be highly unlikely for an S1 bound
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Figure 1. Assessment of L-leucine binding to LeuT WT by solid state NMR. (A) Cartoon illustration of experimental approach. 15N enriched L-leucine
substrate is added to detergent reconstituted LeuT, which is subsequently crystallized using large scale sitting drop vapour diffusion. Rod-shaped
microcrystals form within 24 hr and can be readily harvested. (PDB ID: 3F3E) (B) LeuT WT purified in NaCl (red) and LeuT purified in KCl (black). 15N
L-Leucine specific peak is indicated by an asterix with a chemical shift of 38.2 ppm. Spectra are tentatively intensity normalized to the 15N natural
abundance signal from the LeuT backbone amides. Signal-to-noise is calculated to be 21. (C) 23Na-NMR of LeuT WT (red) and LeuT WT in KCl (black) in
presence of leucine. Minor peak at  8.9 ppm represents the shape of one or two structural sodium molecules. Despite inequivalent location of the two
sodium sites in the LeuT, the coordination mechanism is almost identical which might account for the observation of a single peak in the 23Na-NMR
spectrum instead of two distinct peaks.
DOI: 10.7554/eLife.19314.003
The following figure supplements are available for figure 1:
Figure supplement 1. Functional characterization of LeuT WT.
DOI: 10.7554/eLife.19314.004
Figure supplement 2. Microscopy image of LeuT microcrystals.
DOI: 10.7554/eLife.19314.005
Figure supplement 3. 1D 15N CP/MAS spectrum of frozen and lyophilized LeuT WT samples.
DOI: 10.7554/eLife.19314.006
Figure supplement 4. 15N L-leucine spectrum substrate peak for LeuT WT.
DOI: 10.7554/eLife.19314.007
Figure supplement 5. In-solution 1D 15N spectra of free 98% 15N L-leucine at different pH.
DOI: 10.7554/eLife.19314.008
Figure supplement 6. 1D 13C CP/MAS spectrum of microcrystalline LeuT WT samples.
DOI: 10.7554/eLife.19314.009
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substrate and a putative S2 site-bound substrate to have the same chemical shift as the environment
of the putative S2 binding site markedly differs from the S1 binding site. As a major difference, the
proposed S2 binding site does not involve direct sodium binding (Shi et al., 2008)
In conclusion, although all LeuT samples used in the present study were prepared in DDM at low
concentration to exclude previously reported detrimental effects on the S2 binding site, we were
only able to identify one single substrate signal at 38.2 ppm in the 15N spectra and one set of signals
in the 13C spectrum (Figure 2—figure supplement 2). We note, however, that at our current signal-
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Figure 2. Effects of S1 and S2 site mutations on the L-leucine chemical shift . (A–B) Cartoon representation
displaying the location of F253 in the S1 site and L400 in the proposed S2 site based on PDB: 3USG (Wang et al.,
2012a). (C) 15N 1D NMR spectrum of LeuT WT (red), F253A (green) and L400S (blue). Inset: Close-up of L-leucine
specific peak. Spectra are tentatively intensity normalized to the 15N natural abundance signal from the LeuT
amides.
DOI: 10.7554/eLife.19314.010
The following figure supplements are available for figure 2:
Figure supplement 1. Comparison of spectra derived from LeuT WT purified and crystallized in either 1 mM (red)
or 5 uM (purple) free leucine.
DOI: 10.7554/eLife.19314.011
Figure supplement 2. Power spectra of LeuT WT (red), F253A (green) and L400S (blue).
DOI: 10.7554/eLife.19314.012
Figure supplement 3. Comparison of LeuT WT and LeuT F253A in the presence of 1 mM free substrate.
DOI: 10.7554/eLife.19314.013
Figure supplement 4. Cartoon representation of S1 bound substrate (green).
DOI: 10.7554/eLife.19314.014
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to-noise ratio (~20), we would not be able to detect species populated less than 5% of the structural
ensemble. Based on the minor change in chemical shift in the F253A (S1) mutant, and the completely
unaltered signal for the L400S (S2) mutant we reason that the observable bound leucine is located at
the S1 binding site, thus supporting the idea that LeuT exhibit one single central binding site. We
cannot exclude that the detection of S2 binding may only be possible upon the complete transition
of the transporter towards a specific (yet unknown) conformation or that unfavourable crystal con-
tacts might complicate S2 binding. However, several crystal structures have shown the binding of
antidepressants, which overlaps with the putative S2 site, using these exact conditions (Singh et al.,
2007; Zhou et al., 2009). As previously proposed for LeuT (Piscitelli et al., 2010) we speculate that
the S2 substrate binding site, if present, is rather a transient site, responsible for optimal functional-
ity of the transporter.
Materials and methods
Protein expression and purification
Expression of LeuT WT from Aquifex aeolicus was performed according to the protocol described
previously (Billesbølle et al., 2015). LeuT WT was expressed in E. coli C41(DE3) transformed with
pET16b encoding C-terminally 8xHis-tagged transporter (expression plasmid was kindly provided by
Dr E. Gouaux, Vollum Institute, Portland, Oregon, USA). Briefly, isolated bacterial membranes were
solubilized in 1% DDM (Anatrace, USA) in the presence of 1 mM 98% 15N-L-Leucine (Cambridge
isotopes, Tewksbury, MA) and the protein was bound to nickel-charged affinity resin (Life
Technologies, Carlsbad, CA). Subsequently, protein was eluted in 20 mM Tris-HCl (pH 8.0), 200 mM
KCl, 0.05% DDM, 1 mM 15N-L-Leucine and 300 mM imidazole (KCl sample) or in the same buffer
containing NaCl instead of KCl (NaCl sample). LeuT F253A and L400S variants were generated from
the leuT gene using a QuikChange kit (Agilent Technologies, Santa Clara, CA) and purified similarly
to the LeuT WT protein with the difference that 5 mM of 13C-15N-L-Leucine (Cambridge Isotopes)
was used for co-purification, and the salt content in all buffers consisted of 50 mM NaCl and 150
KCl. The LeuT F253A variant in the presence of 1 mM substrate was prepared similar to the NaCl
sample. Subsequently, all LeuT samples were dialyzed for approx. 36 hr at 4˚C in the respective elu-
tion buffer without imidazole.
Functional characterization of LeuT WT
Functional characterization of the LeuT WT purified in KCl was performed using a scintillation prox-
imity assay (SPA) (Quick and Javitch, 2007). Saturation binding of [3H]leucine (50.2 Ci/mmol; Perki-
nElmer, Waltham, MA) to purified LeuT WT was performed with 100 ng/well (1.66 pmol) of protein
in buffer composed of 20 mM Tris-HCl (pH 8.0), 200 mM NaCl, 0.05% DDM, 20% glycerol in the
presence of 1.25 mg/ml copper chelate (His-Tag) YSi beads (PerkinElmer). Sodium-dependency was
measured at fixed [3H]leucine concentration of 100 nM with increasing concentrations of NaCl (NaCl
was substituted with KCl for equal ionic strength) again using 100 ng/well LeuT WT. [3H]Leucine
binding was monitored using MicroBeta liquid scintillation counter (PerkinElmer) and data were fit-
ted to a one-site saturation or dose-response function, respectively, using Prism 7 software (Graph-
Pad, San Diego, CA).
Preparation of microcrystals
Microcrystalline samples were produced by large scale sitting drop vapour diffusion method. 1 mL
of the protein sample solutions were mixed 1:1 with the crystallization buffer composed of 100 mM
NaCl (or KCl), 120 mM MgCl2, 28% PEG400, 100 mM MES or HEPES pH 6.5. The crystallization was
carried out at 18˚C. After approximately 20 hr a white precipitate could be harvested by centrifuga-
tion and transferred directly to the rotor. All samples were freshly prepared immediately before use.
Microcrystals where visualized using a Leica M125 microscope with a 1.0x PlanApo objective.
Lyophilized protein preparation
Protein for lyophilisation was depleted of glycerol during dialysis, snap-freezed in liquid nitrogen
and added to a freeze drier. The remaining powder could be transferred directly to the rotor.
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Solution NMR
15N-L-Leucine was dissolved to a final concentration of 1 mM in the following buffer: 20 mM Tris-HCl
(pH 8.0), 200 mM KCl, 0.05% DDM and added to an Economy WG5 NMR tube. The Experiment was
run on a Bruker Avance III 500 MHz operating at a Larmor frequency of 50.667 MHz for 15N. The
directly detected 15N spectra were recorded using a recovery delay of 2 s and an acquisition time of
500 ms. The total number of 1024 scans were used.
Solid sate NMR
Microcrystalline LeuT nitrogen spectra were recorded on Bruker Avance III 800 MHz wide bore (89
mm) spectrometer equipped with a 4 mm MAS HCN efree probe. Spectra were obtained at 275 K
(measured temperature), at 12500 Hz magic-angle-spinning. 15N CP/MAS experiments were run for
60 K scans in blocks of 10 K scans and the magnet was fine-tuned between each block. Cross-polari-
zation contact time was set to 1750 us. Initial recovery delay was set to 3 s. Protons were decoupled
at 86 kHz during acquisition. 13C CP/MAS experiments were run for 2 K scans. Cross-polarization
contact time was set to 2000 us. The initial recovery delay was set to 3 s. Spectra were displayed
using a 1, 10 or 100 Hz line broadening for EM window function in topspin.
Sodium MAS NMR spectra were recorded on a Bruker Avance NMR spectrometer operating at a
Larmor frequency of 105.8 MHz for 23Na using a double resonance probe equipped for 4 mm (o.d.)
rotors. All spectra were recorded at room temperature employing a central transition selective 90
degree pulse (1.8 ms), a recycle delay of 2 s, an acquisition time of 40.9 ms, a spectral width of 75.19
kHz and a spin rate of either 9 or 10 kHz. The spectra are referenced to crystalline NaCl at 7.1 ppm.
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